Table 1.

Clinical characteristics of 112 CKD patients.

Males/females (no.)	59/53
Age (years)	63.6 ± 14.0
f(HNA) (%)	30.0 ± 6.1
Body mass index (kg/m2)	22.5 ± 4.4
eGFR (mL/min/1.73 m2)	30.7 ± 15.6
Creatinine (mg/dL)	2.2 ± 1.4
Blood urea nitrogen (mg/dL)	33 ± 20
Aspartate transaminase (IU/L)	20 ± 6.7
Alanine transaminase (IU/L)	16 ± 9.4
Total protein (g/dL)	6.9 ± 0.7
Albumin (g/dL)	3.8 ± 0.5
C-reactive protein (mg/dL)	0.23 ± 0.4
Uric acid (mg/dL)	6.5 ± 1.5
Hemoglobin (g/dL)	12.5 ± 1.6
Ferritin (ng/mL)	105 ± 105
Transferrin saturation (%)	27 ± 11
Plasma glucose (mg/dL)	105 ± 32
Hemoglobin A1c (%)	5.7 ± 0.6
Sodium (mEq/L)	141 ± 2.5
Potassium (mEq/L)	4.5 ± 0.5
Chloride (mEq/L)	107 ± 3.3
Sodium-chloride (mEq/L)	33.7 ± 2.9
Corrected calcium (mg/dL)	9.4 ± 0.7
Phosphate (mg/dL)	3.9 ± 0.8
Intact-PTH (pg/mL)	104 ± 106
Fibroblast growth factor-23 (pg/mL)	116 ± 1106
1,25-dihydroxyvitamin D (pg/mL)	38.4 ± 16.2
Urinary protein (g/gCr)	2.3 ± 1.9
ESA user/non-user	26/86
Iron supplementation, yes/no	18/94
ARB, yes/no	67/45
ACEI, yes/no	1/111
Calcium antagonist, yes/no	56/56
Active vitamin D, yes/no	27/85
Phosphate binders, yes/no	9/103
AST-120, yes/no	9/103

eGFR: estimated glomerular filtration rate, PTH: parathyroid hormone, ESA: erythropoiesis-stimulating agents. ARB: angiotensin II receptor blocker, ACEI: angiotensin-converting enzyme inhibitor. Values are expressed as the mean ± SD, as appropriate.